Isomorphic Labs

Isomorphic Labs is an artificial intelligence company applying frontier AI to drug discovery, built on and beyond the Nobel Prize-winning AlphaFold protein structure prediction system developed at Google DeepMind.

Its proprietary drug design engine spans target identification, molecular design, and binding prediction across small molecules and biologics.

The company has partnerships with Novartis, Eli Lilly, and Johnson & Johnson, and is advancing internal oncology and immunology candidates toward clinical trials.